title: Second IASLC Workshop on Combined Radiotherapy and Chemotherapy Modalities in Lung Cancer. Biological basis of combined therapy.
authors.forename: R L
authors.initials: RL
authors.lastname: Souhami
authors.forename: O
authors.initials: O
authors.lastname: Brodin
authors.forename: G
authors.initials: G
authors.lastname: Duchesne
authors.forename: J
authors.initials: J
authors.lastname: Goldie
authors.forename: M
authors.initials: M
authors.lastname: Green
authors.forename: M
authors.initials: M
authors.lastname: Kies
authors.forename: K
authors.initials: K
authors.lastname: Mattson
authors.forename: J
authors.initials: J
authors.lastname: Mulshine
authors.forename: N
authors.initials: N
authors.lastname: Saijo
authors.forename: M
authors.initials: M
authors.lastname: Saunders
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004351:Drug Resistance; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D014411:Neoplastic Stem Cells / Q000187:drug effects / Q000528:radiation effects; D011836:Radiation Tolerance
chemical_list: D000970:Antineoplastic Agents